GMED - Globus Medical, Inc.
Globus Medical, Inc. , a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives.
As of May 15, 2026: spot at $76.44, ATM IV 32.8%, net GEX -$77.4K.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Market Cap
- $10.19B
- P/E Ratio
- 17.43
- Beta
- 1.00
- 52-Week Range
- 51.79-101.4
- CEO
- Keith W. Pfeil
- Employees
- 5,300
- IPO Date
- Aug 3, 2012
- Exchange
- NYSE
What GMED Looks Like to Options Traders Today
IV rank of 16.7% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); negative net gamma exposure (-$77.4K) means dealers hedge with trend, amplifying realized volatility and accelerating directional moves; the 25-delta skew (0.059) prices calls richer than puts, often reflecting upside speculation or squeeze risk.
What This Page Covers
The GMED overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked GMED overview questions
- What is GMED?
- GMED is the ticker symbol for Globus Medical, Inc., a listed security. Globus Medical, Inc. , a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. Listed on NYSE. GMED is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the GMED options snapshot look like today?
- As of May 15, 2026, the GMED options snapshot shows spot at $76.44, ATM IV 32.8%, IV rank 16.7%, net GEX -$77.4K, expected move 9.40%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are GMED's key statistics?
- Globus Medical, Inc. (GMED) carries a market capitalization of $10.19B, trailing P/E ratio of 17.43, beta of 1.00 relative to the broader market, 52-week range of 51.79-101.4. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does GMED belong to?
- Globus Medical, Inc. operates in the Healthcare sector, in the Medical - Devices industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare GMED's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the GMED data on this page?
- The options snapshot above is dated May 15, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).